Cargando…

Dose error reduction software in medication safety risk management – optimising the smart infusion pump dosing limits in neonatal intensive care unit prior to implementation

BACKGROUND: Smart infusion pumps with dose error reduction software can be used to prevent harmful medication errors. The aim of this study was to develop a method for defining and assessing optimal dosing limits in a neonatal intensive care unit’s smart infusion pump drug library by using simulatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuitunen, Sini, Kärkkäinen, Krista, Linden-Lahti, Carita, Schepel, Lotta, Holmström, Anna-Riia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902762/
https://www.ncbi.nlm.nih.gov/pubmed/35255846
http://dx.doi.org/10.1186/s12887-022-03183-8
_version_ 1784664658260525056
author Kuitunen, Sini
Kärkkäinen, Krista
Linden-Lahti, Carita
Schepel, Lotta
Holmström, Anna-Riia
author_facet Kuitunen, Sini
Kärkkäinen, Krista
Linden-Lahti, Carita
Schepel, Lotta
Holmström, Anna-Riia
author_sort Kuitunen, Sini
collection PubMed
description BACKGROUND: Smart infusion pumps with dose error reduction software can be used to prevent harmful medication errors. The aim of this study was to develop a method for defining and assessing optimal dosing limits in a neonatal intensive care unit’s smart infusion pump drug library by using simulation-type test cases developed based on medication error reports. METHODS: This mixed-methods study applied both qualitative and quantitative methods. First, wrong infusion rate-related medication errors reported in the neonatal intensive care unit during 2018–2019 were explored by quantitative descriptive analysis and qualitative content analysis to identify the error mechanisms. The researchers developed simulation-type test cases with potential errors, and a literature-based calculation formula was used to set upper soft limits to the drug library. The limits were evaluated by conducting programming of pumps without errors and with potential errors for two imaginary test patients (1 kg and 3.5 kg). RESULTS: Of all medication errors reported in the neonatal intensive care unit, 3.5% (n = 21/601) involved an error or near-miss related to wrong infusion rate. Based on the identified error mechanisms, 2-, 5-, and 10-fold infusion rates, as well as mix-ups between infusion rates of different drugs, were established as test cases. When conducting the pump programming for the test cases (n = 226), no alerts were triggered with infusion rates responding to the usual dosages (n = 32). 73% (n = 70/96) of the erroneous 2-, 5-, and 10-fold infusion rates caused an alert. Mix-ups between infusion rates triggered an alert only in 24% (n = 24/98) of the test cases. CONCLUSIONS: Simulation-type test cases can be applied to assess the appropriateness of dosing limits within the neonatal intensive care unit’s drug library. In developing the test cases, combining hospital’s medication error data to other prospective data collection methods is recommended to gain a comprehensive understanding on mechanisms of wrong infusion rate errors. After drug library implementation, the alert log data and drug library compliance should be studied to verify suitability of dosing limits. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12887-022-03183-8.
format Online
Article
Text
id pubmed-8902762
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89027622022-03-18 Dose error reduction software in medication safety risk management – optimising the smart infusion pump dosing limits in neonatal intensive care unit prior to implementation Kuitunen, Sini Kärkkäinen, Krista Linden-Lahti, Carita Schepel, Lotta Holmström, Anna-Riia BMC Pediatr Research BACKGROUND: Smart infusion pumps with dose error reduction software can be used to prevent harmful medication errors. The aim of this study was to develop a method for defining and assessing optimal dosing limits in a neonatal intensive care unit’s smart infusion pump drug library by using simulation-type test cases developed based on medication error reports. METHODS: This mixed-methods study applied both qualitative and quantitative methods. First, wrong infusion rate-related medication errors reported in the neonatal intensive care unit during 2018–2019 were explored by quantitative descriptive analysis and qualitative content analysis to identify the error mechanisms. The researchers developed simulation-type test cases with potential errors, and a literature-based calculation formula was used to set upper soft limits to the drug library. The limits were evaluated by conducting programming of pumps without errors and with potential errors for two imaginary test patients (1 kg and 3.5 kg). RESULTS: Of all medication errors reported in the neonatal intensive care unit, 3.5% (n = 21/601) involved an error or near-miss related to wrong infusion rate. Based on the identified error mechanisms, 2-, 5-, and 10-fold infusion rates, as well as mix-ups between infusion rates of different drugs, were established as test cases. When conducting the pump programming for the test cases (n = 226), no alerts were triggered with infusion rates responding to the usual dosages (n = 32). 73% (n = 70/96) of the erroneous 2-, 5-, and 10-fold infusion rates caused an alert. Mix-ups between infusion rates triggered an alert only in 24% (n = 24/98) of the test cases. CONCLUSIONS: Simulation-type test cases can be applied to assess the appropriateness of dosing limits within the neonatal intensive care unit’s drug library. In developing the test cases, combining hospital’s medication error data to other prospective data collection methods is recommended to gain a comprehensive understanding on mechanisms of wrong infusion rate errors. After drug library implementation, the alert log data and drug library compliance should be studied to verify suitability of dosing limits. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12887-022-03183-8. BioMed Central 2022-03-08 /pmc/articles/PMC8902762/ /pubmed/35255846 http://dx.doi.org/10.1186/s12887-022-03183-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Kuitunen, Sini
Kärkkäinen, Krista
Linden-Lahti, Carita
Schepel, Lotta
Holmström, Anna-Riia
Dose error reduction software in medication safety risk management – optimising the smart infusion pump dosing limits in neonatal intensive care unit prior to implementation
title Dose error reduction software in medication safety risk management – optimising the smart infusion pump dosing limits in neonatal intensive care unit prior to implementation
title_full Dose error reduction software in medication safety risk management – optimising the smart infusion pump dosing limits in neonatal intensive care unit prior to implementation
title_fullStr Dose error reduction software in medication safety risk management – optimising the smart infusion pump dosing limits in neonatal intensive care unit prior to implementation
title_full_unstemmed Dose error reduction software in medication safety risk management – optimising the smart infusion pump dosing limits in neonatal intensive care unit prior to implementation
title_short Dose error reduction software in medication safety risk management – optimising the smart infusion pump dosing limits in neonatal intensive care unit prior to implementation
title_sort dose error reduction software in medication safety risk management – optimising the smart infusion pump dosing limits in neonatal intensive care unit prior to implementation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902762/
https://www.ncbi.nlm.nih.gov/pubmed/35255846
http://dx.doi.org/10.1186/s12887-022-03183-8
work_keys_str_mv AT kuitunensini doseerrorreductionsoftwareinmedicationsafetyriskmanagementoptimisingthesmartinfusionpumpdosinglimitsinneonatalintensivecareunitpriortoimplementation
AT karkkainenkrista doseerrorreductionsoftwareinmedicationsafetyriskmanagementoptimisingthesmartinfusionpumpdosinglimitsinneonatalintensivecareunitpriortoimplementation
AT lindenlahticarita doseerrorreductionsoftwareinmedicationsafetyriskmanagementoptimisingthesmartinfusionpumpdosinglimitsinneonatalintensivecareunitpriortoimplementation
AT schepellotta doseerrorreductionsoftwareinmedicationsafetyriskmanagementoptimisingthesmartinfusionpumpdosinglimitsinneonatalintensivecareunitpriortoimplementation
AT holmstromannariia doseerrorreductionsoftwareinmedicationsafetyriskmanagementoptimisingthesmartinfusionpumpdosinglimitsinneonatalintensivecareunitpriortoimplementation